Company news

Vericel Corporation news in 2023

Vericel Corporation's news releases, calls and decks from 2023, newest first.

View company

Vericel Reports Third Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

November 7, 2023

Vericel to Present at the Stephens Annual Investment Conference

November 6, 2023

Vericel to Report Third-Quarter 2023 Financial Results on November 8, 2023

October 24, 2023

Vericel Announces Publication of Positive Results from Phase 3 Debride and Protect (DETECT) Study of Thermal Burn Patients Treated with NexoBrid

September 27, 2023

Vericel Announces U.S. Commercial Availability of NexoBrid® (anacaulase-bcdb) for the Treatment of Severe Thermal Burns in Adults

September 19, 2023

Vericel to Present at the Morgan Stanley Global Healthcare Conference

September 5, 2023

Vericel Reports Second Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

August 1, 2023

Vericel to Report Second-Quarter 2023 Financial Results on August 2, 2023

July 19, 2023

Vericel Reports First Quarter 2023 Financial Results and Raises Full-Year 2023 Financial Guidance

May 9, 2023

Vericel to Report First-Quarter 2023 Financial Results on May 10, 2023

April 25, 2023

Vericel to Present at the Canaccord Genuity Musculoskeletal Conference on Tuesday, March 7, 2023

February 27, 2023

Vericel Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Full-Year 2023 Financial Guidance

February 22, 2023

Vericel to Report Fourth-Quarter 2022 Financial Results on February 23, 2023

February 8, 2023

Vericel Announces Preliminary Fourth-Quarter and Full-Year 2022 Financial Results and Accelerated Launch Timeline for MACI Arthroscopic Program

January 9, 2023

Vericel to Present at the 41st Annual J.P. Morgan Healthcare Conference on Wednesday, January 11, 2023

January 3, 2023

Calls in 2023

Decks in 2023